Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Ciclosporin in Psoriasis Plaque Test
NCT00578370Phase 2Completed
- Sponsor
- ISDIN
- Start
- Nov 2007
- Primary completion
- Apr 2008
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of cyclosporine in Psoriasis vulgaris (PV) (5 arms), sponsored by ISDIN. Primary endpoint: Psoriatic infiltrate measured by sonography at 26 days. Started Nov 2007; status: completed.
02
Drugs
cyclosporine
03
Conditions
Psoriasis vulgaris (PV)
Beyond the preview
Go deeper on NCT00578370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00578370.